P1213 The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients

P Puca,F Del Chierico,C Graziani,L Masi,G Coppola,F Di Vincenz,I Capobianco,L R Lopetuso,M R Barbaro,L Masucci,L Putignani,V Petito,G Marasco,M Sanguinetti,G Barbara,A Gasbarrini,F Scaldaferri
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1343
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Escherichia coli Nissle (EcN) 1917 is a Gram-negative bacterium currently used as probiotic in the management of infectious gastroenteritis and ulcerative colitis (UC). We evaluated the effect of administration of EcN on the composition of the gut microbiota and on intestinal permeability in patients affected by UC. Methods Five patients with stable UC were treated with EcN one pill daily for ten days followed by two pills per day for further twenty days. Fecal samples were collected before the treatment (T0), after ten days (T1) and after one month of treatment (T2). Alpha diversity, microbiota composition and taxonomy were analyzed. Results Alpha diversity increased through treatment: Good’s coverage index revealed an increase in the number of operational taxonomic units (OTUs) at T2. At phylum taxonomic level, Firmicutes relative abundance decreased at T1 compared to T0. At family level, Clostridiacae relative abundance at T1 was higher than T0 and T2. The T test on gut microbiota variations at species level reveals the variability at the two timepoints (T0 and T2), with significant increase for Actinomyces, Anaerostipes, Bacteroides, Bulleidia, Corynebacterium, Dialister, Enterobacteriaceae, Erysipelotrichaceae, Finegoldia, Granulicatella, Lactobacillaceae, Peptoniphilus, Phascolarctobacterium, Roseburia, Serratia, Veillonellaceae, Veillonella dispar. Furthermore, the administration of EcN improved intestinal permeability, assessed on a CaCO2 monolayer. Conclusion Treatment with EcN leads to an improvement in the qualitative composition of the gut microbiota in patients affected by UC, in terms of both diversity and taxonomy. These effects are stronger at the end of treatment.
gastroenterology & hepatology
What problem does this paper attempt to address?
This paper aims to explore the role of the probiotic **Escherichia coli Nissle 1917 (EcN)** in the treatment of patients with ulcerative colitis (UC), particularly its impact on the composition of the gut microbiota and intestinal permeability. Specifically, the researchers hope to observe changes in gut microbial diversity and the relative abundance of specific bacterial groups, as well as improvements in gut barrier function, by administering EcN to UC patients during the treatment period. ### Research Background - **Escherichia coli Nissle (EcN) 1917** is a Gram-negative bacterium currently used as a probiotic for managing infectious gastroenteritis and ulcerative colitis (UC). - The researchers aim to evaluate the impact of EcN on the composition of the gut microbiota and intestinal permeability in UC patients. ### Research Methods - **Subjects**: 5 UC patients with stable conditions. - **Treatment Plan**: Patients take one EcN capsule daily for 10 days; then two capsules daily for another 20 days. - **Sample Collection**: Fecal samples are collected before treatment (T0), after 10 days of treatment (T1), and after 1 month of treatment (T2). - **Analysis Indicators**: α-diversity, microbiota composition, and taxonomic analysis. ### Research Results - **α-Diversity**: α-diversity increased during treatment, with Good’s coverage index showing an increase in the number of operational taxonomic units (OTUs) at T2. - **Relative Abundance of Bacterial Groups**: - At the phylum level, the relative abundance of Firmicutes decreased at T1 compared to T0. - At the family level, the relative abundance of Clostridiaceae was higher at T1 than at T0 and T2. - At the genus level, the relative abundance of multiple genera showed significant changes between T0 and T2, including Actinomyces, Anaerostipes, Bacteroides, Bulleidia, Corynebacterium, Dialister, Enterobacteriaceae, Erysipelotrichaceae, Finegoldia, Granulicatella, Lactobacillaceae, Peptoniphilus, Phascolarctobacterium, Roseburia, Serratia, Veillonellaceae, Veillonella dispar, etc. - **Intestinal Permeability**: The use of EcN improved intestinal permeability, as verified by CaCO2 monolayer cell experiments. ### Conclusion - The use of EcN in treating UC patients can improve the qualitative composition of the gut microbiota, including diversity and taxonomic characteristics. These effects are more pronounced at the end of the treatment.